| Product Code: ETC7550403 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Patient Derived Xenograft (PDX) Models Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2021 & 2031F |
3.3 India Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 India Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.7 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing demand for personalized medicine |
4.2.3 Rising investments in healthcare research and development in India |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals for handling PDX models |
4.3.2 High cost associated with setting up and maintaining PDX models in India |
5 India Patient Derived Xenograft (PDX) Models Market Trends |
6 India Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 India Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2021- 2031F |
6.1.4 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2021- 2031F |
6.2 India Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2021- 2031F |
6.2.3 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2021- 2031F |
6.2.4 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2021- 2031F |
6.3 India Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2021- 2031F |
6.3.3 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2021- 2031F |
6.3.4 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2021- 2031F |
6.3.5 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2021- 2031F |
6.3.6 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2021- 2031F |
6.3.7 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2021- 2031F |
6.4 India Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2021- 2031F |
6.4.3 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2021- 2031F |
6.5 India Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2021- 2031F |
6.5.3 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.5.4 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2021- 2031F |
6.5.5 India Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2021- 2031F |
7 India Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 India Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 India Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 India Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Number of research collaborations between Indian institutions and global pharmaceutical companies for PDX model development |
8.2 Percentage increase in funding allocated to cancer research in India |
8.3 Growth in the number of academic institutions incorporating PDX models in their research projects |
9 India Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 India Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.3 India Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 India Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 India Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2024 |
10.2 India Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here